Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Suvranu Ganguli

Vascular & Interventional Radiology Boston, MA Medical Doctor

NPI 1811023492 CMS profile 613945

840 Harrison Ave, Boston, MA 02118

Open in the dashboard

General payments

$878,469

1,094 records reported · program years 2019–2025

Research payments

$3,873

Paid to them · 6 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$81,624 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Suvranu Ganguli of Boston, MA is reported in the CMS Open Payments database as having received $878,469 across 1,094 general payments and $3,873 in research payments paid to them. Separately, studies naming them as principal investigator received $81,624 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $158,759 159
2024 General $157,555 194
2024 Research $3,873 6
2023 General $86,309 132
2022 General $112,086 148
2021 General $151,290 180
2020 General $80,114 92
2019 General $132,355 189

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Suvranu Ganguli
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Suvranu Ganguli were reported at $158,759. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Suvranu Ganguli Vascular & Interventional Radiology median Middle half National median
2019 $132,355 $422 $125–$1,555 $163
2020 $80,114 $200 $68–$652 $114
2021 $151,290 $280 $99–$866 $132
2022 $112,086 $433 $137–$1,497 $149
2023 $86,309 $506 $152–$2,019 $160
2024 $157,555 $556 $175–$1,930 $164
2025 $158,759 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Sirtex Medical Inc $620,125 793 payments
  2. Boston Scientific Corporation $154,278 144 payments
  3. Instylla Inc. $40,442 30 payments
  4. ABK Biomedical USA, Inc. $20,056 21 payments
  5. Medtronic, Inc. $18,422 38 payments
  6. Medtronic Vascular, Inc. $9,643 23 payments
  7. Surefire Medical, Inc. $4,678 13 payments
  8. Philips Electronics North America Corporation $3,294 2 payments
  9. Eisai Inc. $2,520 1 payment
  10. Argon Medical Devices, Inc. $1,000 2 payments
  11. Other $4,010 27 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $540,270 193 payments
  2. Consulting Fee $213,306 89 payments
  3. Travel and Lodging $63,108 419 payments
  4. Honoraria $42,225 22 payments
  5. Food and Beverage $19,559 371 payments
Products named General payments · program years 2019–2025
  1. SIR-Spheres Microspheres $609,577 784 payments
  2. General - Embolics $33,865 10 payments
  3. GENERAL IO ABLATION $29,494 12 payments
  4. Instylla Delivery Kit $28,302 20 payments
  5. General - Therapies $23,856 22 payments
  6. Eye90 microspheres $18,906 19 payments
  7. INSTYLLA MICROCATHETER Liquid Embolics for Interventional Radiology $15,941 8 payments
  8. GENERAL - IO ABLATION $12,267 2 payments
  9. INSTYLLA MICROCATHETER Liquid Embolics for Interventional Radiology $11,062 11 payments
  10. LAVA LES (Liquid Embolic System) $10,548 9 payments
  11. Other $84,436 173 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. ABK Biomedical USA, Inc. $3,873 6 payments

Billing to Medicare

Part B · data year 2024 · 84 billing codes

Paid by Medicare

$31,213

Medicare's payments for the services billed

Medicare patients

144

Average age 71

Services billed

367

64 women, 80 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 53%
Chronic kidney disease 49%
Arthritis 36%
Heart failure 35%
Ischemic heart disease 33%
Depression 31%
Cancer 29%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

1,100 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular & Interventional Radiology in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record